Use and description |
Fasoracetam is the newest member of the racetam family of nootropics that is currently being developed as a potential non-stimulant ADHD treatment. In 2015, fasoracetam was accepted by the US Food and Drug Administration’s Investigational New Drug program, which grants the developers permission to start human clinical trials and ship the drug across state lines. |
Physical Characters and Index |
Product Name:Sunifiram CAS:314728-85-3 Molecular Formula:C14H18N2O2 Molecular Weight:246.3 Appearance:White powder. Melting point:92-94°C Boiling point:442.0±38.0 °C(Predicted) Storage conditions:2-8°C |